Combined Therapy with Traditional Chinese Medicine and Antiplatelet Drugs for Ischemic Heart Disease: Mechanism, Efficacy, and Safety
Ischemic heart disease is a significant risk factor that threatens human health, and antiplatelet drugs are routinely used to treat cases in clinical settings. Chinese medicine for promoting blood circulation and removing blood stasis (PBCRBSCM) can often be combined with antiplatelet drugs to treat...
Guardado en:
Autores principales: | Zongliang Yu, Xiaoya Li, Xiaonan Zhang, Dan Li, Yimeng Gu, Min Wu, Longtao Liu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Hindawi Limited
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a2bc4704f0d14b80a94a51cc6f01dfa5 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Correlation between Palpitations below the Heart in Traditional Chinese Medicine and Autonomic Nerve Function Based on Heart Rate Variability: A Case-Control Study
por: Chengcheng Song, et al.
Publicado: (2021) -
The Challenges of Ethical Review in Clinical Research of Traditional Chinese Medicine
por: Jie Zhang, et al.
Publicado: (2021) -
Use of Traditional Chinese Medicine and Its Impact on Medical Cost among Urban Ischemic Stroke Inpatients in China: A National Cross-Sectional Study
por: Zhengwei Huang, et al.
Publicado: (2021) -
Traditional Chinese Medicine for adjuvant treatment of breast cancer: Taohong Siwu Decoction
por: Huajuan Jiang, et al.
Publicado: (2021) -
Efficacy and Safety of Chinese Medicine in Treating Arrhythmia: Meta-Analysis of Randomized Controlled Trials
por: Hanyu He, et al.
Publicado: (2021)